Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has been given a consensus rating of “Moderate Buy” by the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $33.00.

A number of brokerages recently weighed in on OPCH. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several large investors have recently bought and sold shares of the stock. Westfield Capital Management Co. LP grew its holdings in Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares during the period. Global Alpha Capital Management Ltd. increased its stake in Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after buying an additional 25,905 shares during the period. Graypoint LLC purchased a new position in Option Care Health in the fourth quarter valued at about $1,161,000. Victory Capital Management Inc. grew its stake in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Option Care Health during the 4th quarter valued at $327,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Up 1.3 %

Shares of OPCH opened at $32.66 on Friday. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.85. The company’s fifty day moving average is $30.81 and its two-hundred day moving average is $28.24. The firm has a market cap of $5.40 billion, a PE ratio of 27.45, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.